Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2005-06-16
2011-10-04
Bristol, Lynn (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C530S387300, C530S388220
Reexamination Certificate
active
08029790
ABSTRACT:
Monoclonal antibodies (mAbs) having thyroid stimulating activity (TSAb), especially full or considerably agonistic activity, or thyroid blocking activity (TBAb), which are obtainable by genetic immunization of mice, or fragments (F(ab′)2, Fab or Fv) or humanized forms of such monoclonal antibodies or single chain forms (SCA; scFv) of such fragments, which antibodies, or their fragments, compete with bovine TSH for epitopes of the human TSHr, compete with autoantibodies from sera from Graves' patients as well as with autoantibodies from sera from patients harboring blocking autoantibodies for epitopes of the human TSHr, bind to conformational epitopes of the human TSHr located in the first 281 amino acids of the human TSHr, and usually also bind to TSFR receptors (TSHr) from different animals. Various uses of such antibodies, or of peptides corresponding to variable regions of such antibodies, are also described and claimed.
REFERENCES:
patent: 95/23865 (1995-09-01), None
patent: 00/61637 (2000-10-01), None
patent: 03/018632 (2003-03-01), None
patent: 2004/003019 (2004-06-01), None
patent: 2004/050708 (2004-06-01), None
Muehlberg et al. (Endocrinology 145(4):1539-1545 (2004)).
MacCallum et al. (J. Mol. Biol. (1996) 262:732-745).
De Pascalis et al. The Journal of Immunology (2002) 169, 3076-3084.
Casset et al. (2003) BBRC 307, 198-205.
Vajdos et al. (2002) J. Mol. Biol. 320, 415-428.
Holm et al (2007) Mol. Immunol. 44: 1075-1084.
Chen et al. J. Mol. Bio. (1999) 293, 865-881.
Wu et al. J. Mol. Biol. (1999) 294, 151-162.
Brummell et al. (Biochemistry 32:1180-1187 (1993)).
Kobayashi et al. (Protein Engineering 12:879-844 (1999)).
Burks et al. (PNAS 94:412-417 (1997)).
Jang et al. (Molec. Immunol. 35:1207-1217 (1998)).
Brorson et al. (J. Immunol. 163:6694-6701 (1999)).
Coleman (Research in Immunol. 145:33-36 (1994)).
Ward et al. (Nature 341:544-546 (1989)).
Smith-Gill et al. (J. Immunol. 139:4135-4144 (1987)).
Kumar et al. (J. Biol. Chem. 275:35129-35136 (2000)).
Song et al. (Biochem Biophys Res Comm 268:390-394 (2000)).
Dufner (Trends Biotechnol. 24(11):523-29 (2006)).
Costagliola et al. (Molec. Endocrinol. 18(12):3020-3034 (Dec. 2004)).
Sanders et al., “Thyroid-Stimulating Monoclonal Antibodies”, Thyroid, vol. 12(12) 2002, 1043-1050.
Kosugi et al., “Identification of Thyroid-Stimulating Antibody-Specific Interaction Sites in the N-Terminal Region of the Thyrotropin Receptor”, Molecular Endocrinology, 1993, vol. 7(1), 114-130.
Costagliola et al., “Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor”, FEBS Letters 436 (1998), 427-433.
Jaume et al., “Thyrotropin Receptor Autoantibodies in Serum Are Present at Much Lower Levels Than Thyroid Peroxidase Autoantibodies: Analysis by Flow Cytometry”, Journal of Clinical Endocrinology and Metabolism, 1997, vol. 82(2), 500-507.
Bergmann Andreas
Costagliola Sabine
Morgenthaler Nils G.
Vassart Gilbert
B.R.A.H.M.S. GmbH
Bristol Lynn
Heslin Rothenberg Farley & & Mesiti P.C.
LandOfFree
Monoclonal thyroid stimulating or blocking antibodies,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal thyroid stimulating or blocking antibodies,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal thyroid stimulating or blocking antibodies,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282547